Zebrafish High-throughput Screen Services
Zebrafish high-throughput screen provides a whole organism approach to assess compound activity in a living vertebrate system. The platform integrates zebrafish models, automated compound handling, high-content imaging, and quantitative phenotypic analysis for efficient evaluation of biological responses in early drug discovery.
Unlike traditional in vitro screening methods, zebrafish-based screening enables researchers to analyze the impact of compounds at different biological levels, such as disease-associated phenotypes, organ-specific responses, developmental alterations, and early toxicity signals. Our Zebrafish High-throughput Screen Services support diverse discovery programs, including hit identification, drug repurposing, target validation, and mechanism-of-action studies.
Why Choose Zebrafish for High-throughput Screening?
Zebrafish offer a scalable platform for whole organism screening to bridge the gap between in vitro screening and mammalian investigations.
Whole-Organism Evaluation
Assess compound activity in an intact vertebrate system capturing efficacy-related responses, physiological impacts and early toxicity signals.
High Throughput Capability
Enable scalable screening formats with low compound requirements and effective evaluation of different candidates.
Real Time Phenotypic Analysis
Employ transparent embryos and larvae for live imaging and quantitative assessment of morphological, behavioral, and molecular responses.
Discovery Integrated Support
Combine efficacy evaluation, toxicity assessment, and mechanism investigation to enable informed candidate prioritization.
Our Zebrafish Screening Platforms
The zebrafish screening platform uses several discovery methodologies to tackle a range of studies, from drug identification to target and pathway analysis. Screening techniques can be designed to be specific to compounds, biological questions and intended outcomes.
Compound Library Screening Services
Zebrafish models can be used to screen various chemical libraries in a high-throughput manner for identification of physiologically active chemicals. This strategy integrates whole organism assessment with quantitative phenotypic analysis for hit discovery, drug repurposing and lead prioritization.
Phenotypic Drug Screening Services
Phenotypic drug screening screens candidate compounds for disease relevant biological phenotypes in living zebrafish models. This approach enables the characterization of morphological, behavioral, fluorescence and organ-specific phenotypes, enabling in vivo efficacy assessment and phenotype-driven drug development.
Target-Based Screening Services
Target-based screening assays modification of specific molecular targets or signaling pathways in a whole organism setting. This method enables target validation, route analysis and mechanism of action studies by reporter models, genetic models and functional readouts.
Applications
Our Zebrafish High-throughput Screen Services support a wide range of drug discovery and biomedical research applications.
Drug Discovery
Identify active compounds and prioritize candidates through rapid in vivo evaluation.
Drug Repurposing
Evaluate approved therapeutics and known bioactive molecules for new therapeutic opportunities.
Lead Identification and Optimization
Compare candidate compounds and assess biological activity to support early lead selection.
Target Validation and Mechanism Studies
Investigate target relevance and pathway regulation using reporter and genetic zebrafish models.
Disease Model Research
Apply zebrafish disease models to study disease mechanisms and evaluate potential therapeutic interventions.
Toxicity-Informed Screening
Integrate early safety assessment with efficacy evaluation to improve candidate prioritization.
Why Choose Our Zebrafish Screening Services?
Diverse Zebrafish Models
Customized Screening Strategies
Advanced Imaging Platforms
Quantitative Data Analysis
Integrated Efficacy & Safety Evaluation
End-to-End Discovery Support